ProCE Banner Activity

Expert Insights on Diagnosing and Managing Perinatal and Postpartum Depression

Clinical Thought

Learn about the pathophysiology of perianatal and postpartum depression as we know it today and what treatment options are available for those who experience major depressive episodes during their pregnancy and/or after childbirth.

Released: April 08, 2024

Expiration: April 07, 2025

Share

Faculty

Anita H. Clayton

Anita H. Clayton, MD, DLFAPA, IF

Wilford W. Spradlin Professor and Chair
Department of Psychiatry & Neurobehavioral Sciences
Professor of Clinical Obstetrics & Gynecology
University of Virginia School of Medicine
Charlottesville, Virginia

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Sage Therapeutics, Inc. and Biogen.

Biogen

Sage Therapeutics, Inc.

Disclosure

Primary Author

Michael K. Gibson, MD, PhD, FACP

Associate Professor of Medicine
Vanderbilt University Medical Center
Nashville, Tennessee


Anita H. Clayton, MD, DLFAPA, IF

Wilford W. Spradlin Professor and Chair
Department of Psychiatry & Neurobehavioral Sciences
Professor of Clinical Obstetrics & Gynecology
University of Virginia School of Medicine
Charlottesville, Virginia

Anita H. Clayton, MD, DLFAPA, IF: grants: Daré Bioscience, Janssen, Neumora Therapeutics, Otsuka, Relmada Therapeutics; consultant/advisor: AbbVie, Biogen, Brii Biosciences, Fabre-Kramer, Initiator Pharma, Janssen Research & Development, Mycomedica Life Sciences, PureTech Health, Reunion Neuroscience, S1 Biopharma, Sage Therapeutics, Sertsei Pharmaceuticals, Vella Bioscience; stock/stock options: Euthymics, S1 Biopharma.